Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

News Daily News

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

Caitlin E. Cox

July 11, 2023

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

L.A. McKeown

August 23, 2022

News Daily News

Worse Survival for Women After Ruptured AAA Repair

L.A. McKeown

May 11, 2022

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

News Daily News

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Todd Neale

January 20, 2021

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Daily News

Recent Stroke Heightens Risk of Perioperative Events After AVR

Todd Neale

April 25, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Shelley Wood

February 23, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Daily News

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Shelley Wood

September 13, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

Shelley Wood

January 20, 2016

News Daily News

No se da Importancia Debida a los Delirios Post-TAVR Poniendo en Peligro a los Pacientes

Shelley Wood

January 20, 2016

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

Advertisement

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Same-Day Discharge Possible After Many Percutaneous CV Procedures: Review

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

Worse Survival for Women After Ruptured AAA Repair

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Recent Stroke Heightens Risk of Perioperative Events After AVR

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Delirium Is Under-recognized and Underestimated Following TAVR, Putting Patients in Peril

No se da Importancia Debida a los Delirios Post-TAVR Poniendo en Peligro a los Pacientes

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content